Advertisement
Screener

IRADIMED CORPORATION (IRMD) Cost of Revenue

3.1 / 5 stars · 74/120 Roast Me

IRADIMED CORPORATION Cost of Revenue

IRADIMED CORPORATION (IRMD) reported Cost of Revenue of $5.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Expense Statement

us-gaap:CostOfRevenue · last filed 2026-07-31

  • IRADIMED CORPORATION cost of revenue for the quarter ending 2026-06-30 was $5.31M, a 19.13% increase year-over-year.
  • IRADIMED CORPORATION cost of revenue for the quarter ending 2026-03-31 was $5.17M, a 10.65% increase year-over-year.
  • IRADIMED CORPORATION cost of revenue for the quarter ending 2025-12-31 was $5.66M, a 22.30% increase year-over-year.
  • IRADIMED CORPORATION cost of revenue for the quarter ending 2025-09-30 was $4.71M, a 13.87% increase year-over-year.
  • IRADIMED CORPORATION cost of revenue for fiscal 2025 was $19.49M, a 15.38% increase from fiscal 2024.
  • IRADIMED CORPORATION cost of revenue for fiscal 2024 was $16.89M, a 9.66% increase from fiscal 2023.
  • IRADIMED CORPORATION cost of revenue for fiscal 2023 was $15.40M, a 28.15% increase from fiscal 2022.
  • IRADIMED CORPORATION cost of revenue for fiscal 2022 was $12.02M, a 23.10% increase from fiscal 2021.
Period endCost of Revenue 3 monthCost of Revenue 3 month as first filedCost of Revenue 6 monthCost of Revenue 6 month as first filedCost of Revenue 9 monthCost of Revenue 12 monthCost of Revenue 12 month as first filed
2026-06-30$5.31M
10-Q · filed 2026-07-31
$10.47M
10-Q · filed 2026-07-31
$16.13M
derived: sum of 3 quarters · filed 2026-07-31
$20.84M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$5.17M
10-Q · filed 2026-05-01
$10.83M
derived: sum of 2 quarters · filed 2026-05-01
$15.53M
derived: sum of 3 quarters · filed 2026-05-01
$19.99M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$5.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$10.37M
derived: sum of 2 quarters · filed 2026-03-06
$14.82M
derived: sum of 3 quarters · filed 2026-07-31
$19.49M
10-K · filed 2026-03-06
2025-09-30$4.71M
10-Q · filed 2025-11-03
$9.16M
derived: sum of 2 quarters · filed 2026-07-31
$13.83M
10-Q · filed 2025-11-03
$18.46M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$4.45M
10-Q · filed 2026-07-31
$4.45M
10-Q · filed 2025-08-01
$9.12M
10-Q · filed 2026-07-31
$9.12M
10-Q · filed 2025-08-01
$13.75M
derived: sum of 3 quarters · filed 2026-07-31
$17.88M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$4.67M
10-Q · filed 2026-05-01
$4.67M
10-Q · filed 2025-05-05
$9.30M
derived: sum of 2 quarters · filed 2026-05-01
$13.43M
derived: sum of 3 quarters · filed 2026-05-01
$17.35M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31$4.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$8.76M
derived: sum of 2 quarters · filed 2026-03-06
$12.68M
derived: sum of 3 quarters · filed 2026-03-06
$16.89M
10-K · filed 2026-03-06
$16.89M
10-K · filed 2025-03-06
2024-09-30$4.13M
10-Q · filed 2025-11-03
$8.05M
derived: sum of 2 quarters · filed 2025-11-03
$12.26M
10-Q · filed 2025-11-03
$16.30M
derived: sum of 4 quarters · filed 2025-11-03
2024-06-30$3.92M
10-Q · filed 2025-08-01
$8.13M
10-Q · filed 2025-08-01
$12.17M
derived: sum of 3 quarters · filed 2025-09-03
$15.84M
derived: sum of 4 quarters · filed 2025-09-03
2024-03-31$4.21M
10-Q · filed 2025-05-05
$8.25M
derived: sum of 2 quarters · filed 2025-09-03
$11.92M
derived: sum of 3 quarters · filed 2025-09-03
$15.86M
derived: sum of 4 quarters · filed 2025-09-03
2023-12-31$4.04M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03
$7.71M
derived: sum of 2 quarters · filed 2025-09-03
$11.65M
derived: sum of 3 quarters · filed 2025-09-03
$15.40M
10-K/A · filed 2025-09-03
2023-09-30$3.67M
10-Q · filed 2024-10-31
$7.61M
derived: sum of 2 quarters · filed 2024-10-31
$11.36M
10-Q · filed 2024-10-31
$15.01M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30$3.94M
10-Q · filed 2024-08-01
$7.70M
10-Q · filed 2024-08-01
$11.34M
derived: sum of 3 quarters · filed 2024-08-01
$14.21M
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31$3.75M
10-Q · filed 2024-05-02
$7.40M
derived: sum of 2 quarters · filed 2024-05-02
$10.26M
derived: sum of 3 quarters · filed 2024-05-02
$12.84M
derived: sum of 4 quarters · filed 2024-05-02
2022-12-31$3.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
$6.51M
derived: sum of 2 quarters · filed 2024-03-01
$9.09M
derived: sum of 3 quarters · filed 2024-03-01
$12.02M
10-K · filed 2024-03-01
2022-09-30$2.86M
10-Q · filed 2023-11-03
$5.45M
derived: sum of 2 quarters · filed 2023-11-03
$8.38M
10-Q · filed 2023-11-03
$11.00M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30$2.58M
10-Q · filed 2023-08-03
$5.51M
10-Q · filed 2023-08-03
$8.14M
derived: sum of 3 quarters · filed 2023-08-03
$10.64M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31$2.93M
10-Q · filed 2023-05-04
$5.55M
derived: sum of 2 quarters · filed 2023-05-04
$8.06M
derived: sum of 3 quarters · filed 2023-05-04
$10.53M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$2.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$5.12M
derived: sum of 2 quarters · filed 2023-03-02
$7.60M
derived: sum of 3 quarters · filed 2023-03-02
$9.76M
10-K · filed 2023-03-02
2021-09-30$2.50M
10-Q · filed 2022-11-03
$4.98M
derived: sum of 2 quarters · filed 2022-11-03
$7.14M
10-Q · filed 2022-11-03
$9.25M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$2.48M
10-Q · filed 2022-08-05
$4.64M
10-Q · filed 2022-08-05
$6.75M
derived: sum of 3 quarters · filed 2022-08-05
$8.70M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$2.16M
10-Q · filed 2022-05-06
$4.27M
derived: sum of 2 quarters · filed 2022-05-06
$6.23M
derived: sum of 3 quarters · filed 2022-05-06
$8.09M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$2.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$4.06M
derived: sum of 2 quarters · filed 2022-03-04
$5.93M
derived: sum of 3 quarters · filed 2022-03-04
$8.14M
10-K · filed 2022-03-04
2020-09-30$1.96M
10-Q · filed 2021-11-05
$3.82M
derived: sum of 2 quarters · filed 2021-11-05
$6.04M
10-Q · filed 2021-11-05
$8.78M
derived: sum of 4 quarters · filed 2022-03-04
2020-06-30$1.86M
10-Q · filed 2021-08-06
$4.08M
10-Q · filed 2021-08-06
$6.82M
derived: sum of 3 quarters · filed 2022-03-04
$8.99M
derived: sum of 4 quarters · filed 2022-03-04
2020-03-31$2.21M
10-Q · filed 2021-05-07
$4.96M
derived: sum of 2 quarters · filed 2022-03-04
$7.12M
derived: sum of 3 quarters · filed 2022-03-04
$8.98M
derived: sum of 4 quarters · filed 2022-03-04
2019-12-31$2.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$4.91M
derived: sum of 2 quarters · filed 2022-03-04
$6.77M
derived: sum of 3 quarters · filed 2022-03-04
$8.82M
10-K · filed 2022-03-04
2019-09-30$2.17M
10-Q · filed 2020-11-06
$4.03M
derived: sum of 2 quarters · filed 2020-11-06
$6.07M
10-Q · filed 2020-11-06
$8.06M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$1.86M
10-Q · filed 2020-08-06
$3.91M
10-Q · filed 2020-08-06
$5.89M
derived: sum of 3 quarters · filed 2021-03-05
$7.72M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$2.05M
10-Q · filed 2020-05-07
$4.03M
derived: sum of 2 quarters · filed 2021-03-05
$5.86M
derived: sum of 3 quarters · filed 2021-03-05
$7.57M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$1.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$3.81M
derived: sum of 2 quarters · filed 2021-03-05
$5.52M
derived: sum of 3 quarters · filed 2021-03-05
$7.21M
10-K · filed 2021-03-05
2018-09-30$1.83M
10-Q · filed 2019-11-07
$3.54M
derived: sum of 2 quarters · filed 2019-11-07
$5.23M
10-Q · filed 2019-11-07
$6.87M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30$1.71M
10-Q · filed 2019-08-07
$3.40M
10-Q · filed 2019-08-07
$5.04M
derived: sum of 3 quarters · filed 2020-03-06
$6.35M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$1.69M
10-Q · filed 2019-05-08
$3.33M
derived: sum of 2 quarters · filed 2020-03-06
$4.64M
derived: sum of 3 quarters · filed 2020-03-06
$5.87M
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$2.95M
derived: sum of 2 quarters · filed 2020-03-06
$4.18M
derived: sum of 3 quarters · filed 2020-03-06
$5.57M
10-K · filed 2020-03-06
2017-09-30$1.31M
10-Q · filed 2018-11-07
$2.54M
derived: sum of 2 quarters · filed 2018-11-07
$3.93M
10-Q · filed 2018-11-07
$5.23M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$1.23M
10-Q · filed 2018-08-08
$2.62M
10-Q · filed 2018-08-08
$3.93M
derived: sum of 3 quarters · filed 2019-03-07
$5.33M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31$1.39M
10-Q · filed 2018-05-08
$2.69M
derived: sum of 2 quarters · filed 2019-03-07
$4.10M
derived: sum of 3 quarters · filed 2019-03-07
$5.84M
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$2.71M
derived: sum of 2 quarters · filed 2019-03-07
$4.45M
derived: sum of 3 quarters · filed 2019-03-07
$6.15M
10-K · filed 2019-03-07
2016-09-30$1.41M
10-Q · filed 2017-11-06
$3.14M
derived: sum of 2 quarters · filed 2017-11-06
$4.85M
10-Q · filed 2017-11-06
$6.35M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$1.74M
10-Q · filed 2017-08-04
$3.44M
10-Q · filed 2017-08-04
$4.94M
derived: sum of 3 quarters · filed 2018-03-08
$6.54M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$1.71M
10-Q · filed 2017-05-05
$3.21M
derived: sum of 2 quarters · filed 2018-03-08
$4.80M
derived: sum of 3 quarters · filed 2018-03-08
$6.22M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$1.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$3.09M
derived: sum of 2 quarters · filed 2018-03-08
$4.51M
derived: sum of 3 quarters · filed 2018-03-08
$5.84M
10-K · filed 2018-03-08
2015-09-30$1.59M
10-Q · filed 2016-11-04
$3.01M
derived: sum of 2 quarters · filed 2016-11-04
$4.34M
10-Q · filed 2016-11-04
$5.26M
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$1.42M
10-Q · filed 2016-08-05
$2.75M
10-Q · filed 2016-08-05
$3.67M
derived: sum of 3 quarters · filed 2017-03-10
$4.63M
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$1.33M
10-Q · filed 2016-05-06
$2.25M
derived: sum of 2 quarters · filed 2017-03-10
$3.21M
derived: sum of 3 quarters · filed 2017-03-10
$4.08M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$918.70K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$1.88M
derived: sum of 2 quarters · filed 2017-03-10
$2.75M
derived: sum of 3 quarters · filed 2017-03-10
$3.40M
10-K · filed 2017-03-10
2014-09-30$959.59K
10-Q · filed 2015-11-10
$1.83M
derived: sum of 2 quarters · filed 2015-11-10
$2.49M
10-Q · filed 2015-11-10
$3.43M
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30$869.75K
10-Q · filed 2015-08-11
$1.53M
10-Q · filed 2015-08-11
$2.47M
derived: sum of 3 quarters · filed 2015-08-11
$3.14M
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31$656.37K
10-Q · filed 2015-05-11
$1.61M
derived: sum of 2 quarters · filed 2015-05-11
$2.27M
derived: sum of 3 quarters · filed 2015-05-11
$3.04M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$948.79K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$1.62M
derived: sum of 2 quarters · filed 2015-03-23
$2.39M
derived: sum of 3 quarters · filed 2015-03-23
$2.85M
10-K · filed 2015-03-23
2013-09-30$669.76K
10-Q · filed 2014-11-13
$1.44M
derived: sum of 2 quarters · filed 2014-11-13
$1.90M
10-Q · filed 2014-11-13
2013-06-30$767.72K
10-Q · filed 2014-08-14
$1.23M
10-Q · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02